India approves first dengue vaccine
India has approved its first dengue vaccine, authorizing the use of Japanese drugmaker Takeda's Qdenga jab, the Health Ministry said Tuesday.
Jul 21, 2026
0
16
MeSH tree: D20.215.894.899.162
India has approved its first dengue vaccine, authorizing the use of Japanese drugmaker Takeda's Qdenga jab, the Health Ministry said Tuesday.
Jul 21, 2026
0
16
Every three to five years, Puerto Rico, a territory of the United States in the Caribbean, experiences epidemic levels of dengue fever, a disease carried by mosquitoes that causes a range of flu-like symptoms, including aches ...
Mar 31, 2026
0
3
Dengue, a mosquito-borne disease, affects millions of people every year across Asia, Africa and Latin America. And it's expanding geographically as warmer temperatures and urban growth allow mosquito populations to thrive ...
Mar 25, 2026
0
9
In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...
Mar 11, 2026
0
18
A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially benefit populations in hard-to-reach regions of the country such as the Amazon, say disease specialists.
Dec 4, 2025
0
10
Warmer weather across the globe is reshaping the landscape of human health. A case in point is dengue fever, a mosquito-borne disease once confined largely to the tropics, which often brings flu-like symptoms, and without ...
Sep 9, 2025
0
23
In a new study, scientists have discovered more about how the body protects against dengue fever, one of the world's most common mosquito-borne illnesses, prompting hopes for more effective vaccines against the disease.
Dengue fever is a potentially life-threatening viral infection transmitted through the bite of infected mosquitoes.
May 19, 2025
0
21
Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).
Feb 24, 2025
0
23
Genomic surveillance of the evolving SARS-CoV-2 virus has been essential for managing the COVID-19 pandemic, helping researchers identify new variants, track their circulation, and create new vaccines that target the most ...
Sep 30, 2024
0
24